Levotuss belongs to the pharmacotherapeutic group: 5.2.1 - Respiratory system. Antitussives and expectorants. Antitussives. Levodropropizine is a new molecule with strong antitussive activity, mainly at the peripheral tracheobronchial level, associated with antiallergic and antibronchospastic activity. In addition, in animals, it has a local anesthetic effect. Levodropropizine has no narcotic activity and does not induce physical or psychological dependence. Therapeutic doses have no effect on the central nervous system. Levodropropizine does not depress respiratory function or mucociliary clearance. Therapeutic Indications: Symptomatic treatment of cough. Sale reserved for individuals over 16 years of age. Non-prescription medicine. Read the information leaflet carefully and if in doubt or if symptoms persist, consult your doctor or pharmacist. See here the eligible counties for delivery and respective MNSRM Sales Locations.
Comment